The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies
Open accessAbstract
Although pulmonary fibrosis can occur in the absence of a clear-cut inciting agent, and without a clinically clear initial acute inflammatory phase, it is more commonly associated with severe lung injury. This may be due to respiratory infections, chronic granulomatous diseases, medications, and connective tissue disorders. Pulmonary fibrosis is associated with permanent pulmonary architectural distortion and irreversible lung dysfunction. Available clinical, radiographic, and autopsy data has indicated that pulmonary fibrosis is central to severe acute respiratory distress syndrome (SARS) and MERS pathology, and current evidence suggests that pulmonary fibrosis could also complicate infection by SARS-CoV-2. The aim of this review is to explore the current literature on the pathogenesis of lung injury in COVID-19 infection. We evaluate the evidence in support of the putative risk factors for the development of lung fibrosis in the disease and propose risk mitigation strategies. We conclude that, from the available literature, the predictors of pulmonary fibrosis in COVID-19 infection are advanced age, illness severity, length of ICU stay and mechanical ventilation, smoking and chronic alcoholism. With no proven effective targeted therapy against pulmonary fibrosis, risk reduction measures should be directed at limiting the severity of the disease and protecting the lungs from other incidental injuries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Cai, Q., Yang, M., Liu, D., Chen, J., Shu, D., Xia, J., Liao, X., Gu, Y., Cai, Q., Yang, Y., et al. (2020) · Engineering · doi:10.1016/j.eng.2020.03.007 · Cited by 1,357
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244 · cited 6×
“SARS-CoV-2 is an enveloped single-stranded, positive sense RNA virus of the Coronaviridae family [16].”
BackgroundInfluentialZhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · cited 1×
“Factors associated with increased disease severity include comorbidities such as hypertension, diabetes, and coronary artery disease [83].”
BackgroundLu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469 · cited 1×
“4%) require intubation with mechanical ventilation [87].”
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
Barrientos, S., Stojadinovic, O., Golinko, M. S., Brem, H., & Tomic‐Canic, M. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2008.00410.x · Cited by 3,583
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M. L., Lescure, F.-X., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007016 · Cited by 2,737
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Role of platelet-derived growth factors in physiology and medicine
Andrae, J., Gallini, R., & Betsholtz, C. (2008) · Genes & Development · doi:10.1101/gad.1653708 · Cited by 2,438
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., et al. (2020) · JAMA · doi:10.1001/jama.2020.4783 · Cited by 2,277
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061 · cited 1×
“Meanwhile, MERS-CoV utilizes dipeptidyl peptidase 4 (DPP4) for viral entry [19, 20].”
BackgroundEpidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Young, B. E., Ong, S. W. X., Kalimuddin, S., Low, J. G., Tan, S. Y., Loh, J., Ng, O.-T., Marimuthu, K., Ang, L. W., Mak, T. M., et al. (2020) · JAMA · doi:10.1001/jama.2020.3204 · Cited by 2,059
Grasselli, G., Pesenti, A., & Cecconi, M. (2020) · JAMA · doi:10.1001/jama.2020.4031 · Cited by 2,023
Richeldi, L., Collard, H. R., & Jones, M. G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30866-8 · Cited by 2,020 · cited 5×
“The median age for the diagnosis of idiopathic pulmonary fibrosis is 65 years, and it rarely occurs before 50 years [42].”
BackgroundInfluentialClinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,008
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., Zhou, M., Chen, L., Meng, S., Hu, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004168117 · Cited by 1,960
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400937101 · Cited by 1,861
TGF-β and epithelial-to-mesenchymal transitions
Zavadil, J., & Böttinger, E. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208927 · Cited by 1,578
Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,419
COVID-19 and smoking: A systematic review of the evidence
Vardavas, C., & Nikitara, K. (2020) · Tobacco Induced Diseases · doi:10.18332/tid/119324 · Cited by 1,380
Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review
Ye, Z., Zhang, Y., Wang, Y., Huang, Z., & Song, B. (2020) · European Radiology · doi:10.1007/s00330-020-06801-0 · Cited by 1,349
Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605669103 · Cited by 1,257
Liu, W., Tao, Z.-W., Wang, L., Yuan, M.-L., Liu, K., Zhou, L., Wei, S., Deng, Y., Liu, J., Liu, H.-G., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000775 · Cited by 1,104
Fibroblasts in fibrosis: novel roles and mediators
Kendall, R. T., & Feghali-Bostwick, C. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00123 · Cited by 1,082
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Liu, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000106015.29070.e7 · Cited by 1,055
Pan, Y., Guan, H., Zhou, S., Wang, Y., Li, Q., Zhu, T., Hu, Q., & Xia, L. (2020) · European Radiology · doi:10.1007/s00330-020-06731-x · Cited by 999
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Azuma, A., Nukiwa, T., Tsuboi, E., Suga, M., Abe, S., Nakata, K., Taguchi, Y., Nagai, S., Itoh, H., Ohi, M., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-571oc · Cited by 954
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies
Tian, S., Xiong, Y., Liu, H., Niu, L., Guo, J., Liao, M., & Xiao, S.-Y. (2020) · Modern Pathology · doi:10.1038/s41379-020-0536-x · Cited by 948
Functional classification of interferon-stimulated genes identified using microarrays
de Veer, M. J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J. M., Silverman, R. H., & Williams, B. R. G. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.912 · Cited by 900
Weiss, S. R., & Leibowitz, J. L. (2011) · Advances in Virus Research · doi:10.1016/b978-0-12-385885-6.00009-2 · Cited by 896
Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867
Pathogenesis of Idiopathic Pulmonary Fibrosis
Wolters, P. J., Collard, H. R., & Jones, K. D. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104706 · Cited by 862
Pulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial
Wilson, J. G., Liu, K. D., Zhuo, H., Caballero, L., McMillan, M., Fang, X., Cosgrove, K., Vojnik, R., Calfee, C. S., Lee, J.-W., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70291-7 · Cited by 759
CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China
Zhou, S., Wang, Y., Zhu, T., & Xia, L. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.20.22975 · Cited by 753
Pattern Recognition Receptors and the Host Cell Death Molecular Machinery
Amarante-Mendes, G. P., Adjemian, S., Branco, L. M., Zanetti, L. C., Weinlich, R., & Bortoluci, K. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02379 · Cited by 749
Bone marrow–derived progenitor cells in pulmonary fibrosis
Hashimoto, N., Jin, H., Liu, T., Chensue, S. W., & Phan, S. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18847 · Cited by 720
Transforming Growth Factor‐β: Major Role in Regulation of Extracellular Matrix
ROBERTS, A. B., HEINE, U. I., FLANDERS, K. C., & SPORN, M. B. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb17931.x · Cited by 696
Liu, J., Zheng, X., Tong, Q., Li, W., Wang, B., Sutter, K., Trilling, M., Lu, M., Dittmer, U., & Yang, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25709 · Cited by 620
Effects of cigarette smoke on the human airway epithelial cell transcriptome
Spira, A., Beane, J., Shah, V., Liu, G., Schembri, F., Yang, X., Palma, J., & Brody, J. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401422101 · Cited by 619
Strzelak, A., Ratajczak, A., Adamiec, A., & Feleszko, W. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15051033 · Cited by 619
Pathology and Pathogenesis of Severe Acute Respiratory Syndrome
Gu, J., & Korteweg, C. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061088 · Cited by 592
Nikolich-Zugich, J., Knox, K. S., Rios, C. T., Natt, B., Bhattacharya, D., & Fain, M. J. (2020) · GeroScience · doi:10.1007/s11357-020-00186-0 · Cited by 577
Idiopathic pulmonary fibrosis: pathogenesis and management
Sgalla, G., Iovene, B., Calvello, M., Ori, M., Varone, F., & Richeldi, L. (2018) · Respiratory Research · doi:10.1186/s12931-018-0730-2 · Cited by 573
Circulating fibrocytes: collagen-secreting cells of the peripheral blood
Quan, T. E., Cowper, S., Wu, S.-P., Bockenstedt, L. K., & Bucala, R. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.10.005 · Cited by 528
Wound re-epithelialization: modulating kerationcyte migration in wound healing
Raja, R. (2007) · Frontiers in Bioscience · doi:10.2741/2277 · Cited by 523
Romagnani, S. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199911000-00009 · Cited by 520
Snijder, E. J., van der Meer, Y., Zevenhoven-Dobbe, J., Onderwater, J. J. M., van der Meulen, J., Koerten, H. K., & Mommaas, A. M. (2006) · Journal of Virology · doi:10.1128/jvi.02501-05 · Cited by 512
Fibroblasts and Myofibroblasts: What Are We Talking About?
Baum, J., & Duffy, H. S. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182116e39 · Cited by 481
Zhang, P., Li, J., Liu, H., Han, N., Ju, J., Kou, Y., Chen, L., Jiang, M., Pan, F., Zheng, Y., et al. (2020) · Bone Research · doi:10.1038/s41413-020-0084-5 · Cited by 440
Willemse, B. W. M., Postma, D. S., Timens, W., & ten Hacken, N. H. T. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00012704 · Cited by 433
Reducing mortality from 2019-nCoV: host-directed therapies should be an option.
Zumla, A., Hui, D. S., Azhar, E. I., Memish, Z. A., & Maeurer, M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30305-6 · Cited by 429
Progressive Preclinical Interstitial Lung Disease in Rheumatoid Arthritis
Gochuico, B. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.59 · Cited by 409
Is Idiopathic Pulmonary Fibrosis an Environmental Disease?
Taskar, V. S., & Coultas, D. B. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200512-131tk · Cited by 383
Follow-up chest radiographic findings in patients with MERS-CoV after recovery
Das, K. M., Lee, E. Y., Singh, R., Enani, M. A., Al Dossari, K., Van Gorkom, K., Larsson, S. G., & Langer, R. D. (2017) · Indian Journal of Radiology and Imaging · doi:10.4103/ijri.ijri_469_16 · Cited by 370 · cited 3×
“Peaked LDH level was found to significantly correlate with the risk of pulmonary fibrosis following MERS-CoV infection [78].”
BackgroundAntiviral treatment of COVID-19
ŞİMŞEK YAVUZ, S., & ÜNAL, S. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2004-145 · Cited by 367
Coker, R. K., Laurent, G. J., Shahzeidi, S., Lympany, P. A., du Bois, R. M., Jeffery, P. K., & McAnulty, R. J. (1997) · Europe PMC (PubMed Central) · Cited by 292
Antonio, G. E., Wong, K. T., Hui, D. S. C., Wu, A., Lee, N., Yuen, E. H. Y., Leung, C. B., Rainer, T. H., Cameron, P., Chung, S. S. C., et al. (2003) · Radiology · doi:10.1148/radiol.2283030726 · Cited by 290
Liu, W., Fontanet, A., Zhang, P., Zhan, L., Xin, Z., Baril, L., Tang, F., Lv, H., & Cao, W. (2006) · The Journal of Infectious Diseases · doi:10.1086/500469 · Cited by 285
New Mechanisms of Pulmonary Fibrosis
Strieter, R. M., & Mehrad, B. (2009) · Chest · doi:10.1378/chest.09-0510 · Cited by 284
SARS: prognosis, outcome and sequelae
CHAN, K., ZHENG, J., Mok, Y., LI, Y., LIU, Y., CHU, C., & Ip, M. (2003) · Respirology · doi:10.1046/j.1440-1843.2003.00522.x · Cited by 260
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019
Barlow, A., Landolf, K. M., Barlow, B., Yeung, S. Y. A., Heavner, J. J., Claassen, C. W., & Heavner, M. S. (2020) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2398 · Cited by 240
Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)
Tse, G. M.-K., To, K.-F., Chan, P. K.-S., Lo, A. W. I., Ng, K.-C., Wu, A., Lee, N., Wong, H.-C., Mak, S.-M., Chan, K.-F., et al. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.013276 · Cited by 238
Acute Respiratory Distress Syndrome: CT Abnormalities at Long-term Follow-up
Desai, S. R., Wells, A. U., Rubens, M. B., Evans, T. W., & Hansell, D. M. (1999) · Radiology · doi:10.1148/radiology.210.1.r99ja2629 · Cited by 231
CHIEN, J., HSUEH, P., CHENG, W., YU, C., & YANG, P. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00942.x · Cited by 225
Risk factors associated with disease severity and length of hospital stay in COVID-19 patients
Liu, X., Zhou, H., Zhou, Y., Wu, X., Zhao, Y., Lu, Y., Tan, W., Yuan, M., Ding, X., Zou, J., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.008 · Cited by 219
Kligerman, S. J., Franks, T. J., & Galvin, J. R. (2013) · RadioGraphics · doi:10.1148/rg.337130057 · Cited by 218
Endothelial activation: intracellular signaling pathways.
Pober, J. S. (2002) · Arthritis Research · doi:10.1186/ar576 · Cited by 208
Mubarak, A., Alturaiki, W., & Hemida, M. G. (2019) · Journal of Immunology Research · doi:10.1155/2019/6491738 · Cited by 199
MO, H., ZENG, G., REN, X., LI, H., KE, C., TAN, Y., CAI, C., LAI, K., CHEN, R., CHAN‐YEUNG, M., et al. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00783.x · Cited by 193
Venkataraman, T., & Frieman, M. B. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.03.022 · Cited by 193
Th17 cytokines in mucosal immunity and inflammation
Guglani, L., & Khader, S. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328335c2f6 · Cited by 185
Chen, J.-Y., Qiao, K., Liu, F., Wu, B., Xu, X., Jiao, G.-Q., Lu, R.-G., Li, H.-X., Zhao, J., Huang, J., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000839 · Cited by 176
Macrophage Activation: Classical Vs. Alternative
Classen, A., Lloberas, J., & Celada, A. (2009) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-396-7_3 · Cited by 174
Li, X., Tjwa, M., Moons, L., Fons, P., Noel, A., Ny, A., Zhou, J. M., Lennartsson, J., Li, H., Luttun, A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci19189 · Cited by 172
Bajwah, S., Higginson, I. J., Ross, J. R., Wells, A. U., Birring, S. S., Riley, J., & Koffman, J. (2013) · Palliative Medicine · doi:10.1177/0269216313497226 · Cited by 168
Pattern recognition receptors—Molecular orchestrators of inflammation in inflammatory bowel disease
Walsh, D., McCarthy, J., O’Driscoll, C., & Melgar, S. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.09.003 · Cited by 160
Wu, F., Su, Z., Yu, B., Chen, Y., Wang, W., Hu, Y., Song, Z., Tao, Z., Tian, J.-H., Pei, Y.-Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.24.919183 · Cited by 156
Basil, M. H. (2007) · Frontiers in bioscience · doi:10.2741/2559 · Cited by 145
Localization of Platelet-Derived Growth Factor and Insulin-Like Growth Factor I in the Fibrotic Lung
Homma, S. A., Nagaoka, I., Abe, H., Takahashi, K., Seyama, K., Nukiwa, T., & Kira, S. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.6.8520779 · Cited by 124
Venkataraman, T., Coleman, C. M., & Frieman, M. B. (2017) · Journal of Virology · doi:10.1128/jvi.00182-17 · Cited by 124
Ng, C. K. (2004) · Thorax · doi:10.1136/thx.2004.023762 · Cited by 120
Xie, L., Liu, Y.-N., Fan, B., Xiao, Y., Tian, Q., Chen, L., Zhao, H., & Chen, W. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-5 · Cited by 118
Ventilator-associated lung injury: a search for better therapeutic targets
Oeckler, R. A., & Hubmayr, R. D. (2007) · European Respiratory Journal · doi:10.1183/09031936.00104907 · Cited by 103
Maeda, A., Hiyama, K., Yamakido, H., Ishioka, S., & Yamakido, M. (1996) · CHEST Journal · doi:10.1378/chest.109.3.780 · Cited by 100
The Effect of Alcohol Consumption on the Risk of ARDS
Simou, E., Leonardi‐Bee, J., & Britton, J. R. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.11.041 · Cited by 99
Xu, J., Gonzalez, E. T., Iyer, S. S., Mac, V., Mora, A. L., Sutliff, R. L., Reed, A., Brigham, K. L., Kelly, P., & Rojas, M. M. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/glp040 · Cited by 95
Inflammation‐associated remodelling and fibrosis in the lung – a process and an end point
Wallace, W. A., Fitch, P. M., Simpson, A. J., & Howie, S. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2006.00515.x · Cited by 94
Wong, K.-T., Antonio, G. E., Hui, D. S. C., Ho, C., Chan, P. L., Ng, W.-H., Shing, K. K., Wu, A. K. L., Lee, N. L. S., Yap, F. H. Y., et al. (2004) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-200411000-00010 · Cited by 92
Hardie, W. D., Davidson, C. R., Ikegami, M., Leikauf, G. D., Cras, T. D. L., Prestridge, A. L., Whitsett, J. A., & Korfhagen, T. R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00020.2008 · Cited by 89
Huang, W., Akhter, H., Jiang, C., MacEwen, M. W., Ding, Q., Antony, V. B., Thannickal, V. J., & Liu, R.-M. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.11.018 · Cited by 83
Wang, J., Wang, B. J., Yang, J., Wang, M., Chen, C., Luo, G., & He, W. (2020) · PubMed · doi:10.3760/cma.j.cn501120-20200307-00132 · Cited by 76
Kershaw, C. D., & Guidot, D. M. (2008) · Europe PMC (PubMed Central) · Cited by 70
Exposures and Idiopathic Lung Disease
Taskar, V. S., & Coultas, D. (2008) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0028-1101277 · Cited by 70
Targeting platelet-derived growth factor as a therapeutic approach in pulmonary fibrosis
Nishioka, Y., Azuma, M., Kishi, M., & Aono, Y. (2013) · The Journal of Medical Investigation · doi:10.2152/jmi.60.175 · Cited by 58
Platelet-derived growth factor-C and -D in the cardiovascular system and diseases
Lee, C., & Li, X. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.09.005 · Cited by 57
Chronic Alcohol Ingestion Primes the Lung for Bleomycin-Induced Fibrosis in Mice
Sueblinvong, V., Kerchberger, V. E., Saghafi, R., Mills, S. T., Fan, X., & Guidot, D. M. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12232 · Cited by 53
Costabel, U., Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Cottin, V., Flaherty, K., Inoue, Y., Kim, D., et al. (2015) · Pneumologie · doi:10.1055/s-0035-1544829 · Cited by 32
Platelet-Derived Growth Factor in Heart Failure
Medamana, J. L., Clark, R. A. F., & Butler, J. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_80 · Cited by 23
Preventing Ventilator-Associated Lung Injury: A Perioperative Perspective
Kimura, S., Stoicea, N., Rosero-Britton, B. R., Shabsigh, M., Branstiter, A., & Stahl, D. L. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00025 · Cited by 14
Preventing ventilator-induced lung injury—what does the evidence say?
Hoegl, S., & Zwißler, B. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.06.135 · Cited by 5
Cited by
Pathophysiology and mechanism of long COVID: a comprehensive review
Castanares-Zapatero, D., Chalon, P., Kohn, L., Dauvrin, M., Detollenaere, J., Maertens de Noordhout, C., Primus-de Jong, C., Cleemput, I., & Van den Heede, K. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2076901 · Cited by 585
The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases
Lee, J.-W., Chun, W., Lee, H. J., Min, J.-H., Kim, S.-M., Seo, J.-Y., Ahn, K.-S., & Oh, S.-R. (2021) · Cells · doi:10.3390/cells10040897 · Cited by 291
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Montero, P., Milara, J., Roger, I., & Cortijo, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126211 · Cited by 254
Hamidi, S. H., Kadamboor Veethil, S., & Hamidi, S. H. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00255-x · Cited by 50
Yeh, J.-J., Lai, J.-N., Lin, C.-L., Hsu, C.-Y., & Kao, C.-H. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047039 · Cited by 16
Metadata
- Authors
- Ojo, A. S., Balogun, S. A., Williams, O. T., & Ojo, O. S.
- Venue
- Pulmonary Medicine
- Publisher
- Wiley
- Published
- 2020-08-11
- Volume
- 2020
- Pages
- 1-10
- ISSN
- 2090-1836 (ISSN-L)
- 2090-1844
- OpenAlex
- W3048402201
- Cited by
- 352
- References
- 108
- FWCI
- 34.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.